ICMR

The Indian Council of Medical Research is India's apex biomedical research body, operating under the Ministry of Health and Family Welfare. It coordinates national outbreak response, funds public health research, and deploys rapid-response teams to disease events across the country. When Kerala confirmed a Nipah case in Kozhikode on 11 June 2026, ICMR deployed a team and co-ordinated contact tracing that reached approximately 100 people, 58 of them healthcare workers. Three consecutive days with no new positives followed, with containment-zone restrictions subsequently eased.

ICMR's role in Kerala's Nipah response has been established since the district's first outbreak in 2018, when Kozhikode recorded 17 deaths from 19 confirmed cases. In recurring outbreaks since then, ICMR has supplied RT-PCR diagnostic capacity (the only available confirmatory test for Nipah, as no bedside rapid test exists), trained teams for contact management protocols, and coordinated with the Kerala state government's health department. The organisation also represents India on WHO R&D Blueprint activities for Nipah and the broader Paramyxovirus family, which was designated a priority roadmap pathogen family in a WHO publication issued in March 2026.

ICMR functions as both a research funder and an operational response body, a combination that sets it apart from purely regulatory counterparts. Its mandate spans the country's research hospitals (including the National Institute of Virology in Pune, which handles high-consequence pathogen diagnostics), surveillance networks, and academic partnerships. In the context of Nipah, ICMR's laboratory network provides the confirmatory RT-PCR capacity that is the diagnostic bottleneck for every suspected case.